{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:11:04Z","timestamp":1773277864014,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.autrev.2009.02.034","type":"journal-article","created":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T04:39:09Z","timestamp":1235882349000},"page":"28-33","source":"Crossref","is-referenced-by-count":14,"title":["Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Yi-chi M.","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer B.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey C.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Zen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2009.02.034_bib1","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1158\/1078-0432.CCR-07-0187","article-title":"Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade","volume":"13","author":"Downey","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.autrev.2009.02.034_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.cji.0000178913.41256.06","article-title":"Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer","volume":"28","author":"Blansfield","year":"2005","journal-title":"J Immunother"},{"key":"10.1016\/j.autrev.2009.02.034_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon","volume":"354","author":"Gogas","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2009.02.034_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.autrev.2004.03.003","article-title":"Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity","volume":"3","author":"Oppenheim","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.02.034_bib5","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/ijc.22951","article-title":"Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha","volume":"121","author":"Satzger","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.autrev.2009.02.034_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1023\/A:1021904432489","article-title":"Pilot study on an HLA-A2 peptide vaccine using Flt3 ligand as a systemic vaccine adjuvant","volume":"23","author":"McNeel","year":"2003","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2009.02.034_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ajcp\/101.6.698","article-title":"Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis","volume":"101","author":"Okayasu","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2009.02.034_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2009.02.034_bib9","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1200\/JCO.2007.14.6423","article-title":"Next generation of immunotherapy for melanoma","volume":"26","author":"Kirkwood","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.autrev.2009.02.034_bib10","first-page":"550","article-title":"Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice","volume":"34","author":"Kojima","year":"1976","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2009.02.034_bib11","first-page":"362","article-title":"Thyroiditis in T cell-depleted rats: influence of strain, radiation dose, adjuvants and antilymphocyte serum","volume":"21","author":"Penhale","year":"1975","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2009.02.034_bib12","series-title":"Current protocols in immunology","first-page":"15.7.1","article-title":"Experimental autoimmune thyroiditis in the mouse","author":"Kong","year":"2007"},{"key":"10.1016\/j.autrev.2009.02.034_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/eji.1830110216","article-title":"Syngeneic thyroglobulin is immunogenic in good responder mice","volume":"11","author":"ElRehewy","year":"1981","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2009.02.034_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1084\/jem.184.3.1167","article-title":"HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1\u204e0301 (DR3) gene","volume":"184","author":"Kong","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.02.034_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2249.2006.03303.x","article-title":"Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1\u204e0301) transgenic class II-knock-out non-obese diabetic mice","volume":"147","author":"Flynn","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2009.02.034_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.autrev.2008.04.006","article-title":"Autoimmune thyroiditis and ROS","volume":"7","author":"Burek","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.02.034_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.1982.tb36108.x","article-title":"Tolerance to thyroglobulin by activating suppressor mechanisms","volume":"392","author":"Kong","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2009.02.034_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1084\/jem.161.1.72","article-title":"Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease","volume":"161","author":"Sakaguchi","year":"1985","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.02.034_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0090-1229(89)90204-3","article-title":"Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyroglobulin-activated and TSH-induced suppression","volume":"51","author":"Kong","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2009.02.034_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cellimm.2003.11.002","article-title":"CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis","volume":"226","author":"Morris","year":"2003","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2009.02.034_bib21","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4049\/jimmunol.174.5.3111","article-title":"H2A- and H2E-derived CD4+CD25+ regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis","volume":"174","author":"Morris","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2009.02.034_bib22","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1158\/0008-5472.CAN-05-0934","article-title":"Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+CD25+ regulatory T cell-depleted mice","volume":"65","author":"Wei","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2009.02.034_bib23","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2741\/1876","article-title":"Tolerance to autoimmune thyroiditis: CD4+CD25+ regulatory T cells influence susceptibility but do not supersede MHC class II restriction","volume":"11","author":"Morris","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/j.autrev.2009.02.034_bib24","unstructured":"Morris GP, Brown NK, Kong YM. Naturally-existing CD4+CD25+Foxp3+ regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun in press."},{"key":"10.1016\/j.autrev.2009.02.034_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0090-1229(87)90115-2","article-title":"Resistance to experimental autoimmune thyroiditis induced by physiologic manipulation of thyroglobulin level","volume":"45","author":"Lewis","year":"1987","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2009.02.034_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2005.09.003","article-title":"Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody","volume":"26","author":"Morris","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2009.02.034_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00262-003-0444-1","article-title":"Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells","volume":"53","author":"Wei","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.autrev.2009.02.034_bib28","first-page":"1","article-title":"Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice","volume":"2","author":"Jones","year":"2002","journal-title":"Cancer Immun"},{"key":"10.1016\/j.autrev.2009.02.034_bib29","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2009.02.034_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20062259","article-title":"T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis","volume":"204","author":"Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.02.034_bib31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2009.02.034_bib32","first-page":"4632","article-title":"IL-17 induced in experimental autoimmune thyroiditis (EAT) distinguishes autoimmunity from Her-2\/neu specific tumor immunity","author":"Jacob","year":"2008","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1016\/j.autrev.2009.02.034_bib33","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.1158\/0008-5472.CAN-06-4755","article-title":"Control of Her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells","volume":"67","author":"Jacob","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2009.02.034_bib34","unstructured":"Jacob JB, Kong YM, Nalbantoglu I, Snower DP, Wei. WZ. Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity. J Immunol in press."},{"key":"10.1016\/j.autrev.2009.02.034_bib35","first-page":"291","article-title":"Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma","volume":"75","author":"Carlow","year":"1985","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.autrev.2009.02.034_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/gcc.2870030605","article-title":"Outgrowth of stable class I major histocompatibility complex-expressing subsets from immunogenic variants of a murine mammary carcinoma: association with a differentially staining region on chromosome 9","volume":"3","author":"Elliott","year":"1991","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.autrev.2009.02.034_bib37","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-3083.1991.tb02541.x","article-title":"Capacity of CD8+ T cells to reject immunogenic variants of a spontaneous murine carcinoma: lack of non-specific (NK1.1+) effector mechanisms","volume":"33","author":"Elliott","year":"1991","journal-title":"Scand J Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209000755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209000755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T04:21:26Z","timestamp":1545366086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997209000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1568997209000755"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2009.02.034","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}